Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin (Q36510042)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 February 2008
edit
Language Label Description Also known as
English
Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin
scientific article published on 11 February 2008

    Statements

    Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit